Riskpilot← Back to searchSign inGet full accessSwedish Pharma Insights AB
ABActiveOrg 5590363692Brahegatan 10Market research and public opinion polling · NACE 7320Est. 20155 employees
Revenue 2024
SEK 15,2M
-3% vs 2023
EBITDA margin
13.2%
+466% vs 2023
Equity ratio
76.8%
Financial strength
Net profit 2024
SEK 2,2M
+552% vs 2023
| Revenue | SEK 15,2M | -3% |
| EBITDA | SEK 2M | +466% |
| Net profit | SEK 2,2M | +552% |
| Total assets | SEK 11,9M | +9% |
| Equity | SEK 9,1M | +31% |
| Employees | 5 | — |
Legal name
Swedish Pharma Insights AB
Org number
5590363692
Legal form
Aktiebolag
NACE code
7320 · Market research and public opinion polling
Founded
23 november 2015
Share capital
SEK 50 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av Mikkelsen, Kenneth Arthur i förening med en av ledamöterna
Company purpose
Bolaget ska bedriva försäljning av konsulttjänster, marknadsdata och business intelligence inom läkemedelsindustrin, och mjukvaruutveckling i samband med därmed förenlig verksamhet.
Address
Brahegatan 10
Email
finance.sweden@signumlifescience.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 13 077 | 14 620 | 14 425 | 15 747 | 15 243 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 2 112 | 2 753 | 1 648 | −552 | 2 019 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 2 112 | 2 753 | 1 648 | −552 | 2 019 |
| Net financials | −12 | — | −5 | 99 | 186 |
| Profit before tax | 2 101 | 2 753 | 1 644 | −453 | 2 205 |
| Tax | −0 | −110 | −66 | −31 | −17 |
| Net profit | 2 101 | 2 643 | 1 578 | −484 | 2 188 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 689 | 9 022 | 10 468 | 10 871 | 11 887 |
| Equity | 3 210 | 5 853 | 7 430 | 6 947 | 9 135 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 479 | 3 170 | 3 037 | 3 924 | 2 753 |
| Total debt | 2 479 | 3 170 | 3 037 | 3 924 | 2 753 |
EBITDA margin
13.2%
This company
15.8%
Market median
-16% vs market
20202024
Equity ratio
76.8%
This company
38.2%
Market median
+101% vs market
20202024
Return on equity
24.0%
This company
18.4%
Market median
+30% vs market
20202024
Net profit margin
14.4%
This company
8.1%
Market median
+78% vs market
20202024
Asset turnover
1.28×
This company
1.12×
Market median
+14% vs market
20202024
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TE Chief Auditor | Chief Auditor | 2020 |
FJ Authorized Recipient of Service | Authorized Recipient of Service | 2020 |
| Former (2) | ||
LC Chief Executive Officer | Chief Executive Officer | 2021 – 2024 |
LC Chief Executive Officer | Chief Executive Officer | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2026 | |
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Former (5) | ||
| Board of Directors | 2020 – 2020 | |
| Board of Directors | 2020 – 2021 | |
| Board of Directors | 2021 – 2026 | |
| Chairman | 2022 – 2026 | |
| Chairman | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 60% | 60% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
DANSK LAEGEMIDDEL INFORMATION A/S
Swedish Pharma Insights AB (this company)Board members of Swedish Pharma Insights AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tord Erik Sassler | Chief Auditor | 0 companies |
| Fredrik Johan Abel Cassinger | Authorized Recipient of Service | 0 companies |
| Lars Christian Arnt Jønbech | Chief Executive Officer | 0 companies |
| Lars Christian Arnt Jønbech | Chief Executive Officer | 0 companies |
| Kjetil Østreng Evensen | Board of Directors | 0 companies |
| Minna Kristiina Palhamo | Board of Directors | 0 companies |
| Gilhuus-Moe,Christian | Board of Directors | 0 companies |
| Kenneth Arthur Mikkelsen | Chairman | 0 companies |
| Marianne Vogel | Board of Directors | 0 companies |
| Søren-Ulrik Rolsted Fangholm | Chairman | 0 companies |
| Martin Jordt Andersen | Chairman | 0 companies |
| Ouli Onerva Orvokki Uimonen | Board of Directors | 0 companies |